Total Synthesis of Darobactin A.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
10 08 2022
Historique:
pubmed: 29 7 2022
medline: 12 8 2022
entrez: 28 7 2022
Statut: ppublish

Résumé

The collaborative total synthesis of darobactin A, a recently isolated antibiotic that selectively targets Gram-negative bacteria, has been accomplished in a convergent fashion with a longest linear sequence of 16 steps from d-Garner's aldehyde and l-serine. Scalable routes toward three non-canonical amino acids were developed to enable the synthesis. The closure of the bismacrocycle was realized through sequential, halogen-selective Larock indole syntheses, where the proper order of cyclizations proved crucial for the formation of the desired atropisomer of the natural product.

Identifiants

pubmed: 35900216
doi: 10.1021/jacs.2c05891
doi:

Substances chimiques

Aldehydes 0
Amino Acids 0
Phenylpropionates 0
darobactin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

14026-14030

Auteurs

Marko Nesic (M)

Department of Chemistry and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois61801, United States.

David B Ryffel (DB)

Department of Chemistry and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois61801, United States.

Jonathan Maturano (J)

Department of Chemistry and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois61801, United States.

Michael Shevlin (M)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Scott R Pollack (SR)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Donald R Gauthier (DR)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Pablo Trigo-Mouriño (P)

Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey07065, United States.

Li-Kang Zhang (LK)

Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey07065, United States.

Danielle M Schultz (DM)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Jamie M McCabe Dunn (JM)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Louis-Charles Campeau (LC)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

Niki R Patel (NR)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

David A Petrone (DA)

Department of Process Research & Development, Merck & Co., Inc., MRL, Rahway, New Jersey07065, United States.

David Sarlah (D)

Department of Chemistry and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois61801, United States.

Articles similaires

Risk Assessment Plant Leaves Isomerism Humans Stereoisomerism
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase

Aminoacid functionalised magnetite nanoparticles Fe

Spoială Angela, Motelica Ludmila, Ilie Cornelia-Ioana et al.
1.00
Magnetite Nanoparticles Tryptophan Biocompatible Materials Microbial Sensitivity Tests Humans
Intrinsically Disordered Proteins Protein Conformation Nuclear Magnetic Resonance, Biomolecular Amino Acids Computational Biology

Classifications MeSH